OBN BioTuesday: What does it take for a Biotech company to reach mid-size?

4th April 18:15

During the evening we will hear from a panel of speakers who have all grown their companies from small scale to mid-size and will kindly share anecdotes, key learnings and advice on how start-ups can achieve successful and sustainable growth and the pitfalls to avoid along the way.

Discussions will include the following areas: The Importance of appointing a high calibre management team from the very beginning Building your business with acquisition in mind Funding strategies Being aware of Big Pharma partnering activity Planning for IPO Using licensing deals to boost your internal innovation Pros and cons of growing organically through R&D vs buying your way to growth Internal vs External R&D: Where to invest your money within your business

Agenda: 18:15 – Registration and networking 18:45 – Welcome and introductions – John Harris, CEO, OBN & Peter Nolan, CBO, Oxford BioMedica 19:00 – Panel discussion 20.00 – Q&A session 20:30 – Networking over drinks and canapes 21:30 – Evening close

For details, link here: https://www.eventbrite.co.uk/e/obn-biotuesday-what-does-it-take-for-a-biotech-company-to-reach-mid-size-tickets-31929674516